Skip to main content
. 2024 Jun 20;84(7):779–809. doi: 10.1007/s40265-024-02048-x
Evidence clearly indicates that BoNT-A has positive effects in the treatment of M-TMD but it is not superior to standard treatments.
BoNT-A treatment for M-TMDs could cause adverse effects on muscle and bony tissue of major importance that must be considered.
This umbrella review presents the highest level of evidence regarding BoNT-A treatment for M-TMDs, since it included only SRs with low risk of bias/high quality.